Drugs / CD19
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05470777 | Jan 2020 → Jul 2026 overdue | B-cell acute lymphoblastic leukemia | The First Affiliated Hospital of Soochow University | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD19 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05470777 ↗ |
| Route | Other | “received sequential infusion of CD22 and CD19 CAR-T cells” NCT05470777 ↗ |
| Target | CD19 | “sequential CD22/CD19 CAR T cells” PMID 41199560 ↗ Nov 2025 |